Cue Biopharma
64 hedge funds and large institutions have $28.7M invested in Cue Biopharma in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 31 reducing their positions, and 16 closing their positions.
Holders
64
Holders Change
-12
Holders Change %
-15.79%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
13
Reduced
31
Closed
16
Calls
$87K
Puts
$42K
Net Calls
+$45K
Net Calls Change
+$58K
Top Buyers
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$1.01M |
| 3 |
3
Morgan Stanley
New York
|
$569K |
| 4 |
4
Millennium Management
New York
|
$982K |
| 5 |
5
Renaissance Technologies
New York
|
$950K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PHK
76
Point72 Hong Kong
Hong Kong
| – | – | -234 | Closed |
|
|
CS
77
Credit Suisse
Zurich,
Switzerland
| – | – | -16 | Closed |
|
78
Fidelity Investments
Boston,
Massachusetts
| – | – | -10 | Closed |
|
|
HT
79
HAP Trading
New York
| – | – | – | – |
|
80
JPMorgan Chase & Co
New York
| $0 | 39 | – | – |
|
|
CFGS
81
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
82
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 219 | +199 | +995% |
|